157 related articles for article (PubMed ID: 10432007)
21. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
22. Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells.
Ladeda V; Aguirre Ghiso JA; Bal de Kier Joffé E
Exp Cell Res; 1998 Aug; 242(2):515-27. PubMed ID: 9683538
[TBL] [Abstract][Full Text] [Related]
23. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro.
Koochekpour S; Pilkington GJ; Merzak A
Int J Cancer; 1995 Nov; 63(3):450-4. PubMed ID: 7591247
[TBL] [Abstract][Full Text] [Related]
25. CD44s expression in human colon carcinomas influences growth of liver metastases.
Choi SH; Takahashi K; Eto H; Yoon SS; Tanabe KK
Int J Cancer; 2000 Feb; 85(4):523-6. PubMed ID: 10699925
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 splice variants in human primary brain tumors.
Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat.
Lillehei KO; Kong Q; Withrow SJ; Kleinschmidt-DeMasters B
Neurosurgery; 1996 Dec; 39(6):1191-7; discussion 1197-9. PubMed ID: 8938774
[TBL] [Abstract][Full Text] [Related]
28. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.
Ouhtit A; Abd Elmageed ZY; Abdraboh ME; Lioe TF; Raj MH
Am J Pathol; 2007 Dec; 171(6):2033-9. PubMed ID: 17991717
[TBL] [Abstract][Full Text] [Related]
29. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
[TBL] [Abstract][Full Text] [Related]
30. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
Bodell WJ
Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
[TBL] [Abstract][Full Text] [Related]
31. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
32. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
Kulprathipanja NV; Kruse CA
J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
[TBL] [Abstract][Full Text] [Related]
33. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.
Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC
J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768
[TBL] [Abstract][Full Text] [Related]
34. Gamma-glutamyl transferase expression in higher-grade astrocytic glioma.
Schäfer C; Fels C; Brucke M; Holzhausen HJ; Bahn H; Wellman M; Visvikis A; Fischer P; Rainov NG
Acta Oncol; 2001; 40(4):529-35. PubMed ID: 11504314
[TBL] [Abstract][Full Text] [Related]
35. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
Iida N; Bourguignon LY
J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
[TBL] [Abstract][Full Text] [Related]
36. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.
Tapscott SJ; Miller AD; Olson JM; Berger MS; Groudine M; Spence AM
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8185-9. PubMed ID: 8058777
[TBL] [Abstract][Full Text] [Related]
38. Schwann cell tumors express characteristic patterns of CD44 splice variants.
Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
[TBL] [Abstract][Full Text] [Related]
39. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
[TBL] [Abstract][Full Text] [Related]
40. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
